Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

"Never has this side of Raleigh established a nice high-end community like this," the developer said. Jim Segrave’s long connection to entrepreneurship led him to launch a private jet company that has ...

Here’s what you’ll learn when you read this story: An Australian scientist says probabilities are the leading cause of the Bermuda Triangle disappearances. Add in suspect weather, and iffy plane and ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...